Pneumococcal macrolide resistance - myth or reality?

[1] The role of advanced generation macrolides in the prophylaxis and treatment of Mycobacterium avium complex (MAC) infections [J]. DRUGS, 1997, 54 (01) : 69 - 80

[2] Comparison of the plasma, urine and blister fluid pharmacokinetics of clarithromycin and azithromycin in normal subjects [J]. CLINICAL DRUG INVESTIGATION, 1997, 13 (03) : 152 - 161

[3] Erythromycin, clarithromycin, and azithromycin: Are the differences real? [J]. CLINICAL THERAPEUTICS, 1996, 18 (01) : 56 - 72

[4] AMSDEN GW, 1998, 4 INT C MACR AZ STRE

[5] Arason VA, 1996, BMJ-BRIT MED J, V313, P387

[6] BALDWIN DR, 1990, EUR RESPIR J, V3, P886

[7] Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1997, 29 (03) : 173 - 186

[8] Pharmacokinetics of oral azithromycin in serum, urine, polymorphonuclear leucocytes and inflammatory vs non-inflammatory skin blisters in healthy volunteers [J]. CLINICAL DRUG INVESTIGATION, 1998, 15 (02) : 159 - 167

[9] COMMUNITY-ACQUIRED PNEUMONIA [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) : 1618 - 1624

[10] Community-acquired pneumonia in adults: Guidelines for management [J]. CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) : 811 - 838

[1] The role of advanced generation macrolides in the prophylaxis and treatment of Mycobacterium avium complex (MAC) infections [J]. DRUGS, 1997, 54 (01) : 69 - 80

[2] Comparison of the plasma, urine and blister fluid pharmacokinetics of clarithromycin and azithromycin in normal subjects [J]. CLINICAL DRUG INVESTIGATION, 1997, 13 (03) : 152 - 161

[3] Erythromycin, clarithromycin, and azithromycin: Are the differences real? [J]. CLINICAL THERAPEUTICS, 1996, 18 (01) : 56 - 72

[4] AMSDEN GW, 1998, 4 INT C MACR AZ STRE

[5] Arason VA, 1996, BMJ-BRIT MED J, V313, P387

[6] BALDWIN DR, 1990, EUR RESPIR J, V3, P886

[7] Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1997, 29 (03) : 173 - 186

[8] Pharmacokinetics of oral azithromycin in serum, urine, polymorphonuclear leucocytes and inflammatory vs non-inflammatory skin blisters in healthy volunteers [J]. CLINICAL DRUG INVESTIGATION, 1998, 15 (02) : 159 - 167

[9] COMMUNITY-ACQUIRED PNEUMONIA [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) : 1618 - 1624

[10] Community-acquired pneumonia in adults: Guidelines for management [J]. CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) : 811 - 838